Tributylmethylammonium

Tributylmethylammonium

SCHEMBL238424

CCCC[N+](C)(CCCC)CCCC.[Br-]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Tributylmethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 10/20 0.55
SLC22A1 O15245 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
ALOX12 P18054 1/20 0.47
HIF1A Q16665 1/20 0.47
HSD17B10 Q99714 1/20 0.47
HSP90AA1 P07900 1/20 0.46
RAD52 P43351 1/20 0.46
HTT P42858 1/20 0.45
SLC22A2 O15244 1/20 0.44
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tributylmethylammonium SCHEMBL93610 0.96 SLC22A1 (0.56) DNM1SLC22A1HTTSLC22A2
Tributylmethylammonium SCHEMBL29403115 0.93 SLC22A1 (0.53) DNM1SLC22A1HTTSLC22A2
Tributylmethylammonium SCHEMBL21409548 0.93 SLC22A1 (0.53) DNM1SLC22A1HSP90AA1RAD52HTT
Tributylmethylammonium SCHEMBL125277 0.93 SLC22A1 (0.53) DNM1SLC22A1HSP90AA1RAD52HTT
Tributylmethylammonium SCHEMBL3321318 0.93 SLC22A1 (0.53) DNM1SLC22A1HTTSLC22A2
Tributylmethylammonium SCHEMBL4617487 0.93 SLC22A1 (0.53) DNM1SLC22A1HTTSLC22A2
Tributylmethylammonium SCHEMBL165919 0.93 SLC22A1 (0.53) DNM1SLC22A1HSP90AA1RAD52HTT
Tributylmethylammonium SCHEMBL239485 0.93 SLC22A1 (0.53) DNM1SLC22A1HTTSLC22A2
Tributylmethylammonium SCHEMBL16028454 0.93 SLC22A1 (0.53) DNM1SLC22A1HTTSLC22A2
Bromide SCHEMBL5087237 0.90 DNM1 (0.63) DNM1SLC22A1SMN1; SMN2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 586 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US claimed
US-20250381550-A1 CARBON DISULFIDE TREATED MATERIALS AND METHODS OF PURIFYING FLUIDS USING THE SAME ZENITH PURIFICATION LLC (US) 2025-12-18 US claimed
EP-4638452-A1 PROCESS FOR THE PREPARATION OF 7-(4-CHLOROBENZYL)-1-(3-HYDROXYPROPYL)-3-METHYL-8-(3-(TRIFLUOROMETHOXY)-PHENOXY)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE Boehringer Ingelheim International GmbH (DE) 2025-10-29 EP claimed
CN-119976882-A Method for synthesizing hierarchical pore molecular sieve 中国石油大学(华东) 2025-05-13 CN claimed
CN-119297397-A Electrolyte, preparation method thereof and battery 同济大学 2025-01-10 CN claimed
US-20240208976-A1 PROCESS FOR THE PREPARATION OF 7-(4-CHLOROBENZYL)-1-(3-HYDROXYPROPYL)-3-METHYL-8-(3-(TRIFLUOROMETHOXY)-PHENOXY)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2024-06-27 US claimed
WO-2024133476-A1 PROCESS FOR THE PREPARATION OF 7-(4-CHLOROBENZYL)-1-(3-HYDROXYPROPYL)-3-METHYL-8-(3-(TRIFLUOROMETHOXY)-PHENOXY)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2024-06-27 WO claimed
CN-118127539-A Method for synthesizing triphenyl phosphate by electrocatalytic oxidation of phosphate ions 南方科技大学 2024-06-04 CN claimed
CN-117940527-A Optically clear UV and thermally curable epoxy compositions 汉高股份有限及两合公司 2024-04-26 CN claimed
CN-117865789-A Synthesis method of glutaric acid 中科合成油技术股份有限公司 2024-04-12 CN claimed
EP-0666277-A2 Method for making aromatic polycarbonates GENERAL ELECTRIC COMPANY (US) 1995-08-09 EP claimed
US-5391692-A Method for making aromatic polycarbonates GENERAL ELECTRIC COMPANY (US) 1995-02-21 US claimed
EP-0615857-A1 Recording sheets containing monoammonium compounds XEROX CORPORATION (US) 1994-09-21 EP claimed
US-5320902-A Suitable for use in ink jet printing XEROX CORPORATION (US) 1994-06-14 US claimed
EP-0309711-B1 IMPROVED METHOD FOR THE PREPARATION OF ANILINOFUMARATE AMERICAN CYANAMID COMPANY (US) 1993-02-03 EP claimed
US-4814486-A FOR HERBICIDES AMERICAN CYANAMID COMPANY (US) 1989-03-21 US claimed
US-4487722-A Method of preparing 4-(α-hydrocarbyl-α-cyanomethyl)2,6-di-substituted phenols ETHYL CORPORATION (US) 1984-12-11 US claimed
EP-0004606-B1 PROCESS FOR PREPARING ANILINE COMPOUNDS ETHYL CORPORATION (US) 1982-03-10 EP claimed
US-4186147-A DISPLACEMENT OF THIOCYANOANILINE WITH AN ALCOHOL TO FORM THIOALKYL ANILINE ETHYL CORPORATION (US) 1980-01-29 US claimed
EP-0004606-A2 Process for preparing aniline compounds ETHYL CORPORATION (US) 1979-10-17 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208976-A1 PROCESS FOR THE PREPARATION OF 7-(4-CHLOROBENZYL)-1-(3-HYDROXYPROPYL)-3-METHYL-8-(3-(TRIFLUOROMETHOXY)-PHENOXY)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE DPYD, P2RX7, DHPS DNM1 2170/4885SLC22A1 4403/4885SMN1; SMN2 1973/4885
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES TET2, ASIC1, PIEZO1 DNM1 2538/4885SLC22A1 2747/4885SMN1; SMN2 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.